Nasdaq · Healthcare
BGM Group Ltd. (BGM)
As-reported financials and recent SEC filings for BGM Group Ltd., latest fiscal period FY2024. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$25.1M
Net income
$-1.4M
Net margin
-5.7%
Diluted EPS
$-0.20
ROE
-3.3%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25.1M | $46.5M | $64.9M | $57.1M | $50.0M |
| Gross profit | $4.1M | $1.8M | $6.2M | $5.6M | $7.5M |
| Operating income | $-563,771 | $-2.6M | $2.1M | $2.4M | $4.8M |
| Net income | $-1.4M | $-7.8M | $1.1M | $3.2M | $5.1M |
| Diluted EPS | $-0.20 | $-1.08 | $0.15 | $0.45 | $0.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K2026-06-17
View on EDGAR →6-K2026-06-09
View on EDGAR →6-K2026-05-18
View on EDGAR →32026-05-14
View on EDGAR →32026-05-14
View on EDGAR →32026-05-14
View on EDGAR →32026-05-14
View on EDGAR →6-K2026-05-07
View on EDGAR →Largest Healthcare peers
Go deeper on BGM
Search BGM Group Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.